Jing-Min Zheng
Overview
Explore the profile of Jing-Min Zheng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
164
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Guo Y, Gan M, Bao J, Zhou H, Yang J, Dai C, et al.
Biomedicines
. 2023 Dec;
11(12).
PMID: 38137415
KDF1 has been reported to be correlated with carcinogenesis. However, its role and mechanism are far from clear. To explore the possible role and underlying mechanism of KDF1 in lung...
2.
Zheng J, Zhou H, Yu H, Xia Y, Yu Q, Qu H, et al.
Cancer Manag Res
. 2021 Oct;
13:7607-7621.
PMID: 34675657
Background: Contradictive results about the direct role of C5a/C5aR1 axis in different cancer cells have been reported. The direct effect of C5a on human renal cell carcinoma (RCC) cells and...
3.
Xu Z, Gan M, Yu H, Mo L, Xia Y, Yu Q, et al.
Urol Int
. 2021 Sep;
106(4):376-386.
PMID: 34515260
Background: Activins and inhibins are structurally related dimeric glycoprotein hormones belonging to the transforming growth factor-β superfamily but whether they are also involved in malignancy is far from clear. No...
4.
Zheng J, Gan M, Yu H, Ye L, Yu Q, Xia Y, et al.
Front Oncol
. 2021 Jun;
11:686678.
PMID: 34136411
KDF1 has been identified as a key regulator of epidermal proliferation and differentiation, but it is unknown whether KDF1 is involved in the pathogenesis of malignancy. No study has reported...
5.
Zheng J, Wang S, Tian X, Che D
Mol Med Rep
. 2020 Nov;
22(6):5326-5338.
PMID: 33174024
The C3a receptor (C3aR) has been reported to be involved in various physiological and pathological processes, including the regulation of cellular structure development. Expression of C3aR has been reported in...
6.
Zheng J, Jiang Z, Chen D, Wang S, Zhao W, Li L
J Diabetes Investig
. 2018 Sep;
10(3):738-744.
PMID: 30239170
Aims/introduction: The aim of the present study was to obtain a full view of the changes of urinary complement activation products in the development of diabetic nephropathy and explore their...
7.
Zheng J, Ren X, Jiang Z, Chen D, Zhao W, Li L
Clin Chim Acta
. 2018 Apr;
482:65-73.
PMID: 29604259
Background: Complement has been suggested to be involved in diabetic nephropathy (DN), but the exact significance and underlying mechanisms remain unclear. Data about renal local complement activation in DN patients...
8.
Gao Q, Qin W, Jia Z, Zheng J, Zeng C, Li L, et al.
Planta Med
. 2009 Jul;
76(1):27-33.
PMID: 19639539
Rhein (4,5-dihydroxyanthraquinone-2-carboxylic acid) is purified from rhubarb (Rheum officinale), a widely used traditional Chinese herb. In our previous studies, rhein was shown to be effective in ameliorating diabetic renal pathological...
9.
Zhang B, Liu Z, Zeng C, Zheng J, Chen H, Li L
J Nephrol
. 2008 Feb;
21(1):110-7.
PMID: 18264944
Objective: In this study, we report on 16 Chinese patients with biopsy-proven lipoprotein glomerulopathy (LPG) investigated for clinical manifestations, pathological characteristics and apolipoprotein E (apoE) genetic analysis. Methods: A retrospective...
10.
Chen S, Liu Z, Zheng J, Zhang X, Li L
J Nephrol
. 2007 Oct;
20(5):568-75.
PMID: 17918142
Mutations of the apolipoprotein E (apo E) gene are thought to play an etiological role in lipoprotein glomerulopathy (LPG), a novel kidney disease. Evidence suggesting that mutated forms of apo...